SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'NPS'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7A_A_PFLA4001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | LEU A 387ASN A 391LEU A 407ARG A 410VAL A 433GLY A 434 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NPS A 601 ( 4.9A)NPS A 601 (-4.5A)NoneNone | 0.53A | 1e7aA-4po0A:47.8 | 1e7aA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7A_B_PFLB4001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 9 | LEU A 387ASN A 391PHE A 403LEU A 407ARG A 410VAL A 433GLY A 434LEU A 453 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NPS A 601 (-4.5A)NoneNoneNPS A 601 (-4.7A) | 0.69A | 1e7aB-4po0A:49.0 | 1e7aB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7B_A_HLTA4001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 5 | ARG A 209LYS A 212ALA A 213ASP A 324GLY A 328 | NPS A 602 (-3.6A)NoneNPS A 602 (-3.3A)NPS A 602 ( 4.4A)NPS A 602 (-3.8A) | 0.86A | 1e7bA-4po0A:46.2 | 1e7bA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7B_A_HLTA4003_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ASN A 391PHE A 403LEU A 407VAL A 433GLY A 434LEU A 453 | NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NoneNoneNPS A 601 (-4.7A) | 0.41A | 1e7bA-4po0A:46.2 | 1e7bA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7B_B_HLTB4003_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 6 | ASN A 391PHE A 403GLY A 434LEU A 453 | NPS A 601 (-4.3A)NoneNoneNPS A 601 (-4.7A) | 0.43A | 1e7bB-4po0A:46.4 | 1e7bB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7B_B_HLTB4003_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 6 | ASN A 391VAL A 433GLY A 434LEU A 453 | NPS A 601 (-4.3A)NoneNoneNPS A 601 (-4.7A) | 0.33A | 1e7bB-4po0A:46.4 | 1e7bB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7C_A_HLTA4001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 5 | ARG A 209ALA A 213ASP A 324GLY A 328 | NPS A 602 (-3.6A)NPS A 602 (-3.3A)NPS A 602 ( 4.4A)NPS A 602 (-3.8A) | 0.57A | 1e7cA-4po0A:39.4 | 1e7cA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7C_A_HLTA4001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 5 | LYS A 212ALA A 213ASP A 324GLY A 328 | NoneNPS A 602 (-3.3A)NPS A 602 ( 4.4A)NPS A 602 (-3.8A) | 0.58A | 1e7cA-4po0A:39.4 | 1e7cA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK1_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ASN A 391LEU A 394LEU A 407TYR A 411LEU A 453SER A 489 | NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 1.07A | 1hk1A-4po0A:46.1 | 1hk1A-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK1_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | GLN A 390LEU A 394LEU A 407TYR A 411LEU A 453SER A 489 | NoneNoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.57A | 1hk1A-4po0A:46.1 | 1hk1A-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK1_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | GLN A 390LEU A 394TYR A 411LYS A 414LEU A 453SER A 489 | NoneNoneNPS A 601 (-4.3A)NPS A 601 (-2.7A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.81A | 1hk1A-4po0A:46.1 | 1hk1A-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK1_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 9 | LEU A 430ARG A 410TYR A 411LYS A 414SER A 489 | NPS A 601 ( 4.0A)NPS A 601 (-4.5A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NPS A 601 (-3.1A) | 1.39A | 1hk1A-4po0A:46.1 | 1hk1A-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK2_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 8 | ASN A 391LEU A 407TYR A 411LEU A 453 | NPS A 601 (-4.3A)NPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-4.7A) | 1.02A | 1hk2A-4po0A:48.8 | 1hk2A-4po0A:74.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK2_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 8 | GLN A 390LEU A 407TYR A 411LYS A 414LEU A 453SER A 489 | NoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.68A | 1hk2A-4po0A:48.8 | 1hk2A-4po0A:74.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK2_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 8 | LEU A 394LEU A 407TYR A 411LYS A 414LEU A 453SER A 489 | NoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.62A | 1hk2A-4po0A:48.8 | 1hk2A-4po0A:74.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK3_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 8 | ASN A 391LEU A 407TYR A 411LEU A 453SER A 489 | NPS A 601 (-4.3A)NPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 1.17A | 1hk3A-4po0A:45.4 | 1hk3A-4po0A:74.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK3_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 8 | GLN A 390LEU A 407TYR A 411LEU A 453SER A 489 | NoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.58A | 1hk3A-4po0A:45.4 | 1hk3A-4po0A:74.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK3_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 8 | GLN A 390TYR A 411LYS A 414LEU A 453SER A 489 | NoneNPS A 601 (-4.3A)NPS A 601 (-2.7A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.85A | 1hk3A-4po0A:45.4 | 1hk3A-4po0A:74.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HK3_A_T44A3002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 8 | LEU A 430ARG A 410LYS A 414SER A 489 | NPS A 601 ( 4.0A)NPS A 601 (-4.5A)NPS A 601 (-2.7A)NPS A 601 (-3.1A) | 1.12A | 1hk3A-4po0A:45.4 | 1hk3A-4po0A:74.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TYR_B_9CRB130_1 (TRANSTHYRETIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 7 | LEU A 430THR A 422LEU A 407VAL A 418 | NPS A 601 ( 4.0A)NoneNPS A 601 ( 4.9A)None | 0.88A | 1tyrB-4po0A:undetectable | 1tyrB-4po0A:12.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_A_1FLA2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 11 | LEU A 387ASN A 391ARG A 410TYR A 411VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NPS A 601 (-4.5A)NPS A 601 (-4.3A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.60A | 2bxeA-4po0A:45.5 | 2bxeA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_A_1FLA2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 11 | LEU A 387ASN A 391TYR A 411LYS A 414VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.58A | 2bxeA-4po0A:45.5 | 2bxeA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_A_1FLA2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 10 | PHE A 206ALA A 210ALA A 213LEU A 331LEU A 347SER A 480LEU A 481VAL A 482 | NoneNoneNPS A 602 (-3.3A)NoneNPS A 602 ( 4.2A)NoneNoneNone | 0.59A | 2bxeA-4po0A:45.5 | 2bxeA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_A_1FLA2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 10 | PHE A 206ALA A 213LEU A 331LEU A 347GLU A 354SER A 480LEU A 481VAL A 482 | NoneNPS A 602 (-3.3A)NoneNPS A 602 ( 4.2A)NPS A 602 ( 4.9A)NoneNoneNone | 0.62A | 2bxeA-4po0A:45.5 | 2bxeA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_B_1FLB2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 9 / 12 | LEU A 387ASN A 391PHE A 403TYR A 411LYS A 414VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NoneNPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.65A | 2bxeB-4po0A:48.1 | 2bxeB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_B_1FLB2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 11 | PHE A 206ALA A 210ALA A 213LEU A 347GLU A 354SER A 480LEU A 481VAL A 482 | NoneNoneNPS A 602 (-3.3A)NPS A 602 ( 4.2A)NPS A 602 ( 4.9A)NoneNoneNone | 0.54A | 2bxeB-4po0A:48.1 | 2bxeB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_B_1FLB2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 11 | PHE A 206ALA A 210ALA A 213LEU A 347LYS A 351SER A 480LEU A 481VAL A 482 | NoneNoneNPS A 602 (-3.3A)NPS A 602 ( 4.2A)NoneNoneNoneNone | 0.59A | 2bxeB-4po0A:48.1 | 2bxeB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_B_1FLB2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 11 | PHE A 206ARG A 209ALA A 210ALA A 213LEU A 347SER A 480LEU A 481VAL A 482 | NoneNPS A 602 (-3.6A)NoneNPS A 602 (-3.3A)NPS A 602 ( 4.2A)NoneNoneNone | 0.73A | 2bxeB-4po0A:48.1 | 2bxeB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXF_A_DZPA2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 9 / 12 | ASN A 391PHE A 403LEU A 407TYR A 411LEU A 430VAL A 433GLU A 450LEU A 453ARG A 485 | NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 ( 4.0A)NoneNoneNPS A 601 (-4.7A)None | 0.59A | 2bxfA-4po0A:45.8 | 2bxfA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXF_B_DZPB2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 9 / 12 | LEU A 387ASN A 391PHE A 403TYR A 411LEU A 430VAL A 433GLU A 450LEU A 453ARG A 485 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NoneNPS A 601 (-4.3A)NPS A 601 ( 4.0A)NoneNoneNPS A 601 (-4.7A)None | 0.68A | 2bxfB-4po0A:49.5 | 2bxfB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_A_IBPA2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 10 / 11 | LEU A 387ASN A 391ARG A 410TYR A 411LYS A 414VAL A 433GLY A 434LEU A 453ARG A 485SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NPS A 601 (-4.5A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNoneNPS A 601 (-4.7A)NoneNPS A 601 (-3.1A) | 0.59A | 2bxgA-4po0A:48.0 | 2bxgA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_A_IBPA2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 8 | ALA A 213GLU A 354SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.3A)NPS A 602 ( 4.9A)NoneNoneNone | 0.60A | 2bxgA-4po0A:48.0 | 2bxgA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_A_IBPA2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 8 | ALA A 213LYS A 351SER A 480LEU A 481 | NPS A 602 (-3.3A)NoneNoneNone | 0.72A | 2bxgA-4po0A:48.0 | 2bxgA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_A_IBPA2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 8 | ARG A 209ALA A 213SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.6A)NPS A 602 (-3.3A)NoneNoneNone | 0.81A | 2bxgA-4po0A:48.0 | 2bxgA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_B_IBPB2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 9 | ASN A 391ARG A 410TYR A 411LYS A 414GLY A 434LEU A 453ARG A 485SER A 489 | NPS A 601 (-4.3A)NPS A 601 (-4.5A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNPS A 601 (-4.7A)NoneNPS A 601 (-3.1A) | 0.54A | 2bxgB-4po0A:48.9 | 2bxgB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_B_IBPB2001_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 9 | ASN A 391GLY A 431LEU A 453ARG A 485SER A 489 | NPS A 601 (-4.3A)NoneNPS A 601 (-4.7A)NoneNPS A 601 (-3.1A) | 1.49A | 2bxgB-4po0A:48.9 | 2bxgB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_B_IBPB2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 10 | ALA A 210ALA A 213LEU A 331LEU A 347LYS A 351SER A 480LEU A 481VAL A 482 | NoneNPS A 602 (-3.3A)NoneNPS A 602 ( 4.2A)NoneNoneNoneNone | 0.74A | 2bxgB-4po0A:48.9 | 2bxgB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_B_IBPB2002_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 7 / 10 | ARG A 209ALA A 210ALA A 213LEU A 331SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.6A)NoneNPS A 602 (-3.3A)NoneNoneNoneNone | 0.87A | 2bxgB-4po0A:48.9 | 2bxgB-4po0A:74.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KP5_B_KANB2002_1 (TRANSCRIPTIONALREGULATOR TCAR) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 3 / 3 | ALA A 406ARG A 410LYS A 414 | NPS A 603 ( 4.0A)NPS A 601 (-4.5A)NPS A 601 (-2.7A) | 0.81A | 3kp5B-4po0A:undetectable | 3kp5B-4po0A:13.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VM4_A_IZPA1_1 (FATTY ACIDALPHA-HYDROXYLASE) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 5 | LEU A 387ARG A 485PRO A 486ALA A 490 | NPS A 601 ( 4.7A)NoneNoneNone | 1.20A | 3vm4A-4po0A:undetectable | 3vm4A-4po0A:19.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 9 / 11 | ASN A 391PHE A 403ARG A 410TYR A 411LYS A 414VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 (-4.3A)NoneNPS A 601 (-4.5A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.53A | 4or0A-4po0A:50.1 | 4or0A-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ALA A 210ALA A 213LYS A 351SER A 480LEU A 481VAL A 482 | NoneNPS A 602 (-3.3A)NoneNoneNoneNone | 0.84A | 4or0A-4po0A:50.1 | 4or0A-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ALA A 213LEU A 327LYS A 351SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.3A)NPS A 602 ( 4.7A)NoneNoneNoneNone | 0.76A | 4or0A-4po0A:50.1 | 4or0A-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ARG A 209ALA A 210ALA A 213SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.6A)NoneNPS A 602 (-3.3A)NoneNoneNone | 0.82A | 4or0A-4po0A:50.1 | 4or0A-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ARG A 209ALA A 213LEU A 327SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.6A)NPS A 602 (-3.3A)NPS A 602 ( 4.7A)NoneNoneNone | 1.02A | 4or0A-4po0A:50.1 | 4or0A-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | PHE A 206ALA A 210ALA A 213SER A 480LEU A 481VAL A 482 | NoneNoneNPS A 602 (-3.3A)NoneNoneNone | 0.68A | 4or0A-4po0A:50.1 | 4or0A-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA603_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 11 | LEU A 198ARG A 199SER A 202LEU A 347ASP A 451LEU A 481 | NoneNoneNoneNPS A 602 ( 4.2A)NoneNone | 0.87A | 4or0A-4po0A:50.1 | 4or0A-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 10 | ASN A 391PHE A 403ARG A 410TYR A 411LYS A 414VAL A 433LEU A 453SER A 489 | NPS A 601 (-4.3A)NoneNPS A 601 (-4.5A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.47A | 4or0B-4po0A:49.7 | 4or0B-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 7 / 9 | ALA A 210ALA A 213LEU A 347LYS A 351SER A 480LEU A 481VAL A 482 | NoneNPS A 602 (-3.3A)NPS A 602 ( 4.2A)NoneNoneNoneNone | 0.84A | 4or0B-4po0A:49.7 | 4or0B-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 7 / 9 | ALA A 213LEU A 327LEU A 347LYS A 351SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.3A)NPS A 602 ( 4.7A)NPS A 602 ( 4.2A)NoneNoneNoneNone | 0.78A | 4or0B-4po0A:49.7 | 4or0B-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 7 / 9 | ARG A 209ALA A 210ALA A 213LEU A 347SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.6A)NoneNPS A 602 (-3.3A)NPS A 602 ( 4.2A)NoneNoneNone | 0.86A | 4or0B-4po0A:49.7 | 4or0B-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 7 / 9 | ARG A 209ALA A 213LEU A 327LEU A 347SER A 480LEU A 481VAL A 482 | NPS A 602 (-3.6A)NPS A 602 (-3.3A)NPS A 602 ( 4.7A)NPS A 602 ( 4.2A)NoneNoneNone | 0.95A | 4or0B-4po0A:49.7 | 4or0B-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB603_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 11 | LEU A 198SER A 202VAL A 343LEU A 347LEU A 481 | NoneNoneNoneNPS A 602 ( 4.2A)None | 0.85A | 4or0B-4po0A:49.7 | 4or0B-4po0A:71.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 12 | LEU A 387ASN A 391PHE A 403TYR A 411VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NoneNPS A 601 (-4.3A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.46A | 4ot2A-4po0A:49.9 | 4ot2A-4po0A:70.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 12 | LEU A 387ASN A 391TYR A 411LYS A 414VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.57A | 4ot2A-4po0A:49.9 | 4ot2A-4po0A:70.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 6 | ALA A 213ASP A 324LEU A 347LYS A 351 | NPS A 602 (-3.3A)NPS A 602 ( 4.4A)NPS A 602 ( 4.2A)None | 0.57A | 4ot2A-4po0A:49.9 | 4ot2A-4po0A:70.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 6 | ALA A 213LEU A 347LYS A 351SER A 480 | NPS A 602 (-3.3A)NPS A 602 ( 4.2A)NoneNone | 0.56A | 4ot2A-4po0A:49.9 | 4ot2A-4po0A:70.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 6 | ARG A 209ALA A 213ASP A 324LEU A 347 | NPS A 602 (-3.6A)NPS A 602 (-3.3A)NPS A 602 ( 4.4A)NPS A 602 ( 4.2A) | 0.74A | 4ot2A-4po0A:49.9 | 4ot2A-4po0A:70.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z69_A_DIFA1008_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | SER A 202ALA A 213TRP A 214VAL A 344LEU A 481VAL A 482 | NoneNPS A 602 (-3.3A)NoneNoneNoneNone | 1.10A | 4z69A-4po0A:36.9 | 4z69A-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBQ_A_DIFA601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 10 / 11 | LEU A 387VAL A 388ASN A 391PHE A 403LEU A 407ARG A 410GLY A 434LEU A 453ARG A 485SER A 489 | NPS A 601 ( 4.7A)NPS A 601 ( 3.7A)NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NPS A 601 (-4.5A)NoneNPS A 601 (-4.7A)NoneNPS A 601 (-3.1A) | 0.71A | 4zbqA-4po0A:50.2 | 4zbqA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBQ_A_DIFA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 8 | LEU A 394ASN A 405ALA A 406VAL A 409 | NoneNPS A 603 (-4.5A)NPS A 603 ( 4.0A)None | 0.38A | 4zbqA-4po0A:50.2 | 4zbqA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBR_A_DIFA601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 9 | LEU A 394ASN A 405ALA A 406VAL A 409ARG A 410 | NoneNPS A 603 (-4.5A)NPS A 603 ( 4.0A)NoneNPS A 601 (-4.5A) | 0.37A | 4zbrA-4po0A:50.2 | 4zbrA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBR_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 12 | LEU A 387ASN A 391LEU A 407TYR A 411LYS A 414GLY A 434LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.60A | 4zbrA-4po0A:50.2 | 4zbrA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBR_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 12 | LEU A 387ASN A 391PHE A 403LEU A 407TYR A 411GLY A 434LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.42A | 4zbrA-4po0A:50.2 | 4zbrA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBR_A_NPSA603_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 10 | ALA A 213LEU A 327LEU A 347SER A 480LEU A 481 | NPS A 602 (-3.3A)NPS A 602 ( 4.7A)NPS A 602 ( 4.2A)NoneNone | 0.55A | 4zbrA-4po0A:50.2 | 4zbrA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBR_A_NPSA603_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 10 | ARG A 209ALA A 213ASP A 324LEU A 327LEU A 347LEU A 481 | NPS A 602 (-3.6A)NPS A 602 (-3.3A)NPS A 602 ( 4.4A)NPS A 602 ( 4.7A)NPS A 602 ( 4.2A)None | 0.73A | 4zbrA-4po0A:50.2 | 4zbrA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DBY_A_DIFA601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 9 | LEU A 394ASN A 405ALA A 406VAL A 409ARG A 410 | NoneNPS A 603 (-4.5A)NPS A 603 ( 4.0A)NoneNPS A 601 (-4.5A) | 0.37A | 5dbyA-4po0A:50.3 | 5dbyA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DBY_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 12 | LEU A 387ASN A 391PHE A 403LEU A 407ARG A 410TYR A 411LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NPS A 601 (-4.5A)NPS A 601 (-4.3A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.54A | 5dbyA-4po0A:50.3 | 5dbyA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DBY_A_NPSA602_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 12 | LEU A 387ASN A 391PHE A 403LEU A 407TYR A 411LYS A 414LEU A 453SER A 489 | NPS A 601 ( 4.7A)NPS A 601 (-4.3A)NoneNPS A 601 ( 4.9A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.65A | 5dbyA-4po0A:50.3 | 5dbyA-4po0A:71.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DQF_A_CZEA613_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ALA A 213ASP A 324LEU A 327GLY A 328LEU A 347GLU A 354 | NPS A 602 (-3.3A)NPS A 602 ( 4.4A)NPS A 602 ( 4.7A)NPS A 602 (-3.8A)NPS A 602 ( 4.2A)NPS A 602 ( 4.9A) | 0.58A | 5dqfA-4po0A:50.0 | 5dqfA-4po0A:71.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DQF_A_CZEA613_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | ALA A 213LEU A 327GLY A 328LEU A 331LEU A 347GLU A 354 | NPS A 602 (-3.3A)NPS A 602 ( 4.7A)NPS A 602 (-3.8A)NoneNPS A 602 ( 4.2A)NPS A 602 ( 4.9A) | 0.65A | 5dqfA-4po0A:50.0 | 5dqfA-4po0A:71.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DQF_A_LCRA612_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | LYS A 212ASP A 324LEU A 327GLY A 328LEU A 331LEU A 347 | NoneNPS A 602 ( 4.4A)NPS A 602 ( 4.7A)NPS A 602 (-3.8A)NoneNPS A 602 ( 4.2A) | 0.91A | 5dqfA-4po0A:50.0 | 5dqfA-4po0A:71.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DQF_A_LCRA612_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 9 | LYS A 212LEU A 216LEU A 327GLY A 328LEU A 331LEU A 347 | NoneNPS A 602 ( 4.8A)NPS A 602 ( 4.7A)NPS A 602 (-3.8A)NoneNPS A 602 ( 4.2A) | 0.73A | 5dqfA-4po0A:50.0 | 5dqfA-4po0A:71.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_A_9SCA601_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 12 | LEU A 387LEU A 423GLY A 434LEU A 453ARG A 485PHE A 488 | NPS A 601 ( 4.7A)NoneNoneNPS A 601 (-4.7A)NoneNone | 0.80A | 6a7pA-4po0A:45.4 | 6a7pA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_A_9SCA601_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 12 | LEU A 387PHE A 403LEU A 423LEU A 453ARG A 485PHE A 488 | NPS A 601 ( 4.7A)NoneNoneNPS A 601 (-4.7A)NoneNone | 1.03A | 6a7pA-4po0A:45.4 | 6a7pA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_A_9SCA601_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 12 | LEU A 387PHE A 403VAL A 418LEU A 453ARG A 485PHE A 488 | NPS A 601 ( 4.7A)NoneNoneNPS A 601 (-4.7A)NoneNone | 1.26A | 6a7pA-4po0A:45.4 | 6a7pA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_A_9SCA601_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 6 / 12 | LEU A 387VAL A 418GLY A 434LEU A 453ARG A 485PHE A 488 | NPS A 601 ( 4.7A)NoneNoneNPS A 601 (-4.7A)NoneNone | 1.28A | 6a7pA-4po0A:45.4 | 6a7pA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_A_9SCA601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 5 | ASN A 391TYR A 411LEU A 460SER A 489 | NPS A 601 (-4.3A)NPS A 601 (-4.3A)NoneNPS A 601 (-3.1A) | 0.97A | 6a7pA-4po0A:45.4 | 6a7pA-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_B_9SCB601_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 12 | LYS A 414LEU A 423LEU A 460PHE A 488LEU A 491 | NPS A 601 (-2.7A)NoneNoneNoneNone | 0.90A | 6a7pB-4po0A:45.4 | 6a7pB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_B_9SCB601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 6 | ASN A 391PHE A 403LEU A 453SER A 489 | NPS A 601 (-4.3A)NoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.93A | 6a7pB-4po0A:45.4 | 6a7pB-4po0A:74.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A7P_B_9SCB601_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 6 | ASN A 391TYR A 411LEU A 453SER A 489 | NPS A 601 (-4.3A)NPS A 601 (-4.3A)NPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.86A | 6a7pB-4po0A:45.4 | 6a7pB-4po0A:74.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CI6_A_NBOA606_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 8 / 12 | ASN A 391PHE A 403ARG A 410TYR A 411VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 (-4.3A)NoneNPS A 601 (-4.5A)NPS A 601 (-4.3A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.48A | 6ci6A-4po0A:46.2 | 6ci6A-4po0A:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CI6_A_NBOA606_1 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 7 / 12 | ASN A 391TYR A 411LYS A 414VAL A 433GLY A 434LEU A 453SER A 489 | NPS A 601 (-4.3A)NPS A 601 (-4.3A)NPS A 601 (-2.7A)NoneNoneNPS A 601 (-4.7A)NPS A 601 (-3.1A) | 0.65A | 6ci6A-4po0A:46.2 | 6ci6A-4po0A:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HQB_A_PQNA2001_0 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM IREACTION CENTERSUBUNIT IX) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 10 | SER A 435GLY A 434LEU A 398GLY A 399LEU A 583 | NoneNoneNPS A 603 (-4.6A)NoneNone | 1.36A | 6hqbA-4po0A:3.76hqbJ-4po0A:undetectable | 6hqbA-4po0A:9.396hqbJ-4po0A:5.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MDQ_A_TESA604_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 8 | LYS A 212ALA A 213GLY A 328GLU A 354 | NoneNPS A 602 (-3.3A)NPS A 602 (-3.8A)NPS A 602 ( 4.9A) | 0.57A | 6mdqA-4po0A:49.9 | 6mdqA-4po0A:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MDQ_A_TESA604_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 5 / 8 | LYS A 212ALA A 213GLY A 328LEU A 331LYS A 351 | NoneNPS A 602 (-3.3A)NPS A 602 (-3.8A)NoneNone | 0.76A | 6mdqA-4po0A:49.9 | 6mdqA-4po0A:10.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MDQ_A_TESA605_0 (SERUM ALBUMIN) |
4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) | 4 / 8 | LYS A 212LEU A 327GLY A 328LEU A 331 | NoneNPS A 602 ( 4.7A)NPS A 602 (-3.8A)None | 0.65A | 6mdqA-4po0A:49.9 | 6mdqA-4po0A:10.46 |